Show
Sort by
-
The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant : breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
-
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
-
- Journal Article
- A1
- open access
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
-
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
-
- Journal Article
- A1
- open access
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
-
- Journal Article
- A1
- open access
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
-
- Journal Article
- A1
- open access
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
-
- Journal Article
- A1
- open access
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
-
- Journal Article
- A1
- open access
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk